P179 Has COVID-19 affected the management of vitamin D status amongst people with cystic fibrosis?

por Ochota, A., Pandya, S., Walshaw, M.
Publicado 2021

EPS1.07 Impact of COVID-19 on cystic fibrosis physiotherapy outpatient clinics

por Scott, E., Ledson, M., Walshaw, M.
Publicado 2021

P138 Rapid implementation of virtual clinics during the COVID-19 pandemic

por Nazareth, D., Sumner, C., Walshaw, M.
Publicado 2021

P086 The impact of COVID-19 in people with cystic fibrosis – a single-centre experience

por Aldous, G., Pinnock, N., Nazareth, D., Walshaw, M.
Publicado 2021

P139 Evaluating the impact of a telemedicine service during the COVID-19 pandemic in people with cystic fibrosis

por Bull, A., FitzMaurice, T.S., Nazareth, D., Walshaw, M.
Publicado 2021

P094 Facilitating cystic fibrosis research during the COVID-19 pandemic

por Burnett, S., Preidt, M., FitzMaurice, T., Walshaw, M., Nazareth, D.
Publicado 2021

P090 A UK survey on changes in managing people with cystic fibrosis during the COVID-19 pandemic

por Hameed, M.S., Kumar, A., Baker, C., Nazareth, D., Walshaw, M.
Publicado 2021

Managing an adult CF population in the COVID-19 pandemic—1 year on

por Nazareth, D, Sumner, C, Daniels, J, Mathews, J, Hyde, G, Walshaw, M
Publicado 2021

ePS4.08 COVID-19 vaccine uptake in adult people with cystic fibrosis

por Mir, M.H., FitzMaurice, T., Wat, D., Aldous, G., Nazareth, D., Walshaw, M.
Publicado 2022

P216 The impact of the COVID-19 pandemic and elexacaftor/tezacaftor/ivacaftor initiation on high-cost medication utilisation in adults living with cystic fibrosis

por Suhel, M.S., Chan, A., Nazareth, D., Wat, D., Walshaw, M.J., Green, D., Frost, F.
Publicado 2023

A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material

por Bediaga, N G, Davies, M P A, Acha-Sagredo, A, Hyde, R, Raji, O Y, Page, R, Walshaw, M, Gosney, J, Alfirevic, A, Field, J K, Liloglou, T
Publicado 2013